This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.
Skip to main content
Rural Health Information Hub
Rural Health Information Hub

FDA: Revocation of Emergency Use of a Drug Product During the COVID-19 Pandemic; Availability

Source
Federal Register
Link
View Full Story
Date
May 21, 2025
Summary
The Food and Drug Administration has revoked Emergency Use Authorizations issued to Fresenius Medical Care North America (Fresenius) multiFiltrate PRO System and multiBic/multiPlus solutions (EUA 048) and to Baxter Healthcare Corp. (Baxter) for REGIOCIT (EUA 068). These revocations are effective January 16, 2025.
Tagged as
Legislation and regulations ยท Pharmacy and prescription drugs